|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 89 No. 6 (March 15), 1997:
pp. 1915-1921
In Vitro Expansion of Hematopoietic Progenitors and Maintenance of Stem Cells: Comparison Between FLT3/FLK-2 Ligand and KIT Ligand
By
Yuji Yonemura,
Hsun Ku,
Stewart D. Lyman, and
Makio Ogawa
From the Department of Medicine, Medical University of South Carolina, Charleston; the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC; and Immunex Corp, Seattle, WA.
 |
ABSTRACT |
The effects of FLT3/FLK-2 ligand (FL) and KIT ligand (KL) on in vitro expansion of hematopoietic stem cells were studied using lineage-negative (Lin-)Sca-1-positive (Sca-1+) c-kit-positive (c-kit+) marrow cells from 5-fluorouracil (5-FU)-treated mice. As single agents, neither FL nor KL could effectively support the proliferation of enriched cells in suspension culture. However, in combination with interleukin-11 (IL-11), both FL and KL enhanced the production of nucleated cells and progenitors. The kinetics of stimulation by FL was different from that by KL in that the maximal expansion by FL of the nucleated cell and progenitor pools required a longer incubation than with KL. We then tested the reconstituting abilities of cells cultured for 1, 2, and 3 weeks by transplanting the expanded Ly5.1 cells together with "compromised" marrow cells into lethally irradiated Ly5.2 mice. Cells that had been expanded with either cytokine combination were able to maintain the reconstituting ability of the original cells. Only cells that had been incubated with KL and IL-11 for 21 days had less reconstituting ability than fresh marrow cells. These results indicate that there can be significant expansion of progenitors in vitro without compromising the reconstituting ability of stem cells. Addition of IL-3 to permissive cytokine combinations significantly reduced the ability of cultured cells to reconstitute the hematopoiesis of irradiated hosts. These observations should provide a basis for a rational approach to designing cytokine combinations for in vitro expansion of hematopoietic stem cells.
| |
INTRODUCTION |
BOTH FLT3/FLK-2 and KIT receptor tyrosine kinases belong to the type III receptor tyrosine kinase family that includes FMS and platelet-derived growth factor receptors.1-9 The ligands for several of these receptors stimulate the proliferation of hematopoietic cells.7,8,10-12 FLT3/FLK-2 transcripts have been detected in murine and human cell populations enriched for hematopoietic stem cells and progenitors and are absent in more mature cells.1-4 In addition, targeted disruption of the flt3/flk-2 gene led to deficiencies in primitive hematopoietic progenitors.13 The FLT3/FLK-2 ligand (FL) is similar to KIT ligand (KL) in that both proteins stimulate the proliferation of primitive hematopoietic progenitors.14-24 Neither factor has much stimulatory activity on its own, but each factor synergizes with other early-acting cytokines such as interleukin-6 (IL-6), IL-11, IL-12, and granulocyte colony-stimulating factor (G-CSF ).17,18,25,26
Currently, there is significant interest in hematology in the in vitro (ex vivo) expansion of hematopoietic stem cells and progenitors.27-40 A number of investigators have already shown that it is possible to increase the number of hematopoietic progenitors in culture by using combinations of early-acting cytokines.41 In studies of murine lymphohematopoietic progenitors in culture, we observed that a combination of FL and IL-11 stimulates production of cells with a blast-like appearance in suspension culture for a longer time than KL-containing cytokine combinations.17 We report here the results of our studies of the effects of FL or KL on the long-term engrafting capability of stem cells. Although kinetic differences exist, both cytokines are capable of yielding committed and uncommitted progenitors without compromising stem cell reconstituting capability in lethally irradiated hosts.
| |
MATERIALS AND METHODS |
Growth factors.
Recombinant soluble human FL was produced in yeast and purified as previously described.14 Purified recombinant murine KL was provided by Kirin Brewery Co (Tokyo, Japan). Medium conditioned by Chinese hamster ovary cells that had been genetically engineered to produce murine IL-3 at a high titer (70,000 U/mL) was a gift from T. Sudo of the Biomaterial Institute (Yokohama, Japan). Purified recombinant human IL-6 was a gift from M. Naruto of Toray Industries (Kamakura, Japan). Purified recombinant human IL-11 was a gift from P. Schendel of the Genetics Institute (Cambridge, MA). Purified recombinant erythropoietin (Ep) was a gift from F.-K. Lin of Amgen (Thousand Oaks, CA). Unless otherwise specified, concentrations of the cytokines used were as follows: FL 100 ng/mL, KL 100 ng/mL, IL-3 200 U/mL, IL-6 100 ng/mL, IL-11 20 ng/mL, and Ep 2 U/mL.
Cell preparations.
Cells from 2- to 5-month-old BDF1 and C57B1/6 mice (Charles River Laboratories, Raleigh, NC) were used in suspension culture, and cells from 2- to 3-month-old C57B1/6 mice (Jackson Laboratories, Bar Harbor, ME) that are congenic for Ly5 allotypes were used in transplantation experiments. 5-Fluorouracil (5-FU; Adria Laboratories, Columbus, OH) was administered intravenously through the tail vein at 150 mg/kg body weight, and bone marrow cells were harvested 2 days later. Single cell suspensions were prepared from pooled femurs and tibiae, and the cells with densities between 1.063 and 1.077 g/mL were collected with gradients of Metrizamide (Accurate Chemical & Scientific Corp, Westburg, NY). The cells were further enriched for progenitors by negative immunomagnetic selection with a mixture of lineage-specific antibodies.42 Lineage-negative (Lin-) cells were incubated with fluorescein isothiocyanate-conjugated monoclonal antibody D7 (anti-Sca-1)43 and biotin-conjugated monoclonal ACK4 (anti-c-kit)44 for 15 minutes on ice. Isotype controls were fluorescein isothiocyanate-conjugated rat IgG2a and biotin-conjugated rat IgG2a. The cells were washed twice with Ca2+, Mg2+-free phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin (BSA; Fraction V; Sigma Chemical Co, St Louis, MO) and incubated with R-phycoerythrin-conjugated Streptavidin (Jackson ImmunoResearch Laboratories, West Grove, PA) for 15 minutes on ice. The cells were washed twice, resuspended in PBS/BSA, and kept on ice until cell sorting. Flow cytometric analysis and cell sorting were performed on a FACStarPlus (Becton Dickinson, San Jose, CA).
Suspension and clonal cell cultures.
One thousand Lin- Sca-1-positive (Sca-1+) c-kit-positive (c-kit+) cells were incubated in each well of a 24-well plate (Falcon, Lincoln Park, NJ) in suspension culture. The culture medium contained  -medium, 20% (vol/vol) fetal calf serum (Intergen, Purchase, NY), 1% deionized Fraction V BSA, 1 × 10-4 mol/L 2-mercaptoethanol (Sigma), and combinations of cytokines. On day 7 of incubation, the cultured cells were diluted, replated in freshly prepared media in 24-well plates at 2,000 or 5,000 cells/mL, and incubated for 7 more days. On day 14, the cultured cells were diluted, replated in freshly prepared media in 24-well plates at 5 or 10 × 104 cells/mL, and incubated for 7 more days. At each time of replating, aliquots were analyzed for colony formation in 35-mm suspension culture dishes (Falcon) containing -medium, 1.2% 1,500-cp methylcellulose (Shinetsu Chemical, Tokyo, Japan), 30% fetal calf serum, 1% BSA, 1 × 10-4 mol/L 2-mercaptoethanol, KL, IL-3, IL-11, and Ep. Total colony-forming units in culture (CFU-C) and the progenitors for granulocyte/erythrocyte/macrophage/megakaryocyte (CFU-GEMM) were determined on day 8 of incubation by in situ observation of the plates on an inverted microscope.45,46
In vivo reconstitution experiments.
Female C57B1/6-Ly5.2 mice were administered single 850-cGy total-body irradiation via a 4 × 106 V linear accelerator. After total-body irradiation of the recipient mice, sorted fresh marrow cells of male C57B1/6-Ly5.1 mice were injected into the tail vein of the recipients together with 4 × 105 "compromised" marrow cells of female C57B1/6-Ly5.2 mice in a final volume of 0.2 mL PBS containing 0.1% BSA. "Compromised" cells had been subjected to two previous rounds of transplantation and regeneration in female mice.47 After 1 to 3 weeks' incubation, fractions of cultured cells were injected into female C57B1/6-Ly5.2 mice together with "compromised" cells. Peripheral blood was obtained from the retro-orbital venous plexus using heparin-coated micropipettes (Drummond Scientific Co, Broomall, PA) 2, 4, and/or 6 months after transplantation. Red blood cells were lysed by 0.15 mol/L NH4Cl. The samples were then used for flow cytometric analysis of donor-derived cells by staining with anti-Ly5.1 (A20-1.7). In all experiments, cultures were initiated with the same number of cells as the "fresh sample." In designated experiments, duplicate cultures were performed so that the entire sample and fractions equivalent to 1/10 and 1/100 of the sample were injected.
| |
RESULTS |
Effects of FL on the expansion of progenitor cells.
First, we determined the optimal concentrations of FL and KL for stimulation of growth of Lin-Sca-1+c-kit+ marrow cells of 5-FU-treated mice. Varying concentrations of FL and KL were added to suspension cultures containing 20 ng/mL IL-11. The optimal doses of both FL and KL were determined to be 100 ng/mL.
Next, we studied the effects of FL as a single factor and in combination with KL and/or IL-11 on the proliferation of Lin-Sca-1+ c-kit+ cells in suspension culture. The results presented in Table 1 are representative of two experiments. As single factors, FL, KL, and IL-11 had little or no effect on the production of total nucleated cells (TNC). When FL or KL were combined with IL-11, significant expansion of both cells and progenitors was observed. However, direct comparison of FL and KL is not meaningful, since the initial cells that were expanded were c-kit+ cells and thus may not represent the physiologic composition of primitive progenitors. KL did not synergize with FL.
Later effects of FL on the expansion of progenitor cells.
We have recently observed that many blast cells persist on day 13 of methylcellulose culture containing FL and IL-11.17 Therefore, in the next set of experiments, we extended suspension culture to 3 weeks and analyzed the effects of two-factor combinations (FL and KL, FL and IL-11, and KL and IL-11) on the expansion of cells and progenitors. The results of one of two similar experiments are presented in Table 2. Again, both the combination of FL and IL-11 and the combination of KL and IL-11 significantly increased the number of cells and CFU-C, whereas the combination of FL and KL showed little synergy. Proliferation of cells and progenitors appeared slower in culture with FL and IL-11 than with KL and IL-11. However, by day 21 of incubation, the number of CFU-C in FL-containing cultures was significantly higher than in KL-containing cultures, even though there were fewer TNC in FL-containing cultures than in KL-containing cultures.
Reconstituting ability of expanded cells.
We then tested the in vivo reconstituting ability of cells expanded with combinations of cytokines. The suspension cultures were initiated with Lin-Sca-1+c-kit+ C57B1/6-Ly5.1 cells. The cultures were serially transferred to new flasks containing fresh media every 7 days to keep cell concentrations at less than 1 × 106/mL as described in the methods. We then transplanted the whole sample or fractions of the sample of cells expanded from 100 enriched cells into lethally irradiated C57B1/6-Ly5.2 mice. As controls, we also transplanted 100, 10, and one enriched marrow cells. The results of analyses of day 14 expanded cells are presented in Table 3. Incubation with the combination of FL and KL barely supported cell proliferation and failed to maintain the population of stem cells. Both the combination of FL and IL-11 and the combination of KL and IL-11 maintained the reconstituting ability of the expanded cells. Monocytes, granulocytes, and T and B lymphocytes of donor cell type were detected in the peripheral blood of mice injected with the expanded cells (Fig 1 and Table 3). Because of the observation (Table 2) that the combination of FL and IL-11 supports maintenance of progenitor cells longer than the combination of KL and IL-11, we next compared the reconstitution ability of cells that were expanded for 7 or 21 days under two different cytokine conditions (Table 4). The cells expanded with FL or KL and IL-11 for 7 days had almost the same reconstituting ability as fresh cells. However, on day 21 of culture, the combination of FL and IL-11 maintained the reconstituting ability of cultured cells much better than the combination of KL and IL-11.
View larger version (35K):
[in this window]
[in a new window]
| Fig 1.
Hematopoietic reconstitution by cells cultured for 14 days in the presence of FL and IL-11. Nucleated cells of the peripheral blood were analyzed using flow cytometry 6 months after transplantation. Thy-1+ cells, B220+ cells, and Mac-1+, Gr-1+ cells of donor (Ly5.1) origin are seen in the peripheral blood of the recipient. Analyses of additional samples are presented in Table 3.
|
|
Finally, we examined the in vivo reconstituting ability of cells expanded in the presence of multiple cytokines. The four cytokine combinations with FL or KL did not enhance the in vivo reconstituting ability of cultured cells versus fresh cells (Table 5, experiment 1). We previously reported that IL-3 and IL-1 possess negative regulatory effects on early B lymphopoiesis,48 T lymphopoiesis,49 and in vitro expansion of stem cells with long-term reconstitution capabilities.50 Therefore, in one experiment, we examined the addition of IL-3 to multiple cytokines. When added to four-cytokine combinations consisting of KL, IL-6, IL-11, and Ep, IL-3 significantly reduced the in vivo reconstituting ability of cultured cells, whereas FL did not (Table 5, experiment 2).
| |
DISCUSSION |
Previously, we reported that combinations of FL and either IL-6, IL-11, or G-CSF support proliferation of primitive hematopoietic progenitors including lymphohematopoietic progenitors.17 In this regard, FL and KL are similar in hematopoietic function, although the number and size of the colonies supported by FL-containing cytokine combinations were smaller than those supported by KL-containing cytokine combinations.17 During the same study, we noted that blast-like cells persist longer in incubation with FL than with KL. FL and KL signal through different but related tyrosine kinase receptors.1,2,14 Because of their similarities and dissimilarities, we compared their effects on the in vitro expansion of progenitors and hematopoietic stem cells with reconstituting capability. Proliferation of the progenitors appeared slower but persisted longer in suspension culture with FL and IL-11 than in culture with KL and IL-11.
We then compared the ability of FL and KL to support in suspension culture the in vivo long-term reconstituting cells. In the presence of IL-11, both factors maintained the reconstituting cells in culture for 14 days. Although there was no apparent expansion of the stem cells, the standard deviations of the means of the results were large. Neither were there apparent differences between the combination of FL and IL-11 and the combination of KL and IL-11. However, there were kinetic differences in the peak production of CFU-C in that for KL it occurred at day 14 and for FL at day 21 or longer. This time course of the reconstituting cells appears to be consistent with that of the progenitors. In our previous studies, we noted a gradual decline of stem cell functions in 2-week suspension cultures with KL and IL-11.50 However, in that series of experiments, we sorted the cultured cells on day 7 for cells with stem cell phenotypes and recultured the enriched cells for 7 more days. The serial dilution technique used in the current studies allowed maintenance of stem cell functions and appeared to be better than the resorting strategies we used previously. It is possible that stem cells change phenotypes during suspension culture. Alternatively, the resorting of cultured cells may have traumatized the stem cells.
As stated in the introduction, many investigators have already shown that it is possible to expand the population of cells and colony-forming cells in suspension culture in the presence of combinations of early-acting cytokines. However, attempts to expand the population of cells that are capable of long-term reconstitution have met with variable success.28,31-33 Recently, Peters et al51 reported that a 48-hour suspension culture of murine marrow cells in the presence of IL-3, IL-6, IL-11, and KL results in impairment of the engrafting capability of the cultured cells. They proposed that expansion of the progenitors may produce a defective long-term repopulating capability of the stem cells. We believe that the reason for their observation is that IL-3 abrogates the long-term reconstitution capability of cultured cells. Results presented herein and in a previous publication50 indicate that cells expanded in the absence of IL-3 or IL-1 maintain reconstituting ability.
In vitro expansion of hematopoietic stem cells promises to be important in clinical stem cell transplantation. We have shown that both FL and KL are capable of expanding the progenitor cell pool without compromising engraftment. Significant kinetic differences appear to exist between the two cytokines, but we have not determined which factor combination is superior. Again, we noted negative effects of IL-3 on the ability of cultured cells to engraft the marrow of recipient mice. Although it is not wise to translate findings in murine systems directly to human cells, cytokine combinations containing IL-3 need to be evaluated carefully for in vitro expansion of human stem cells.
| |
FOOTNOTES |
Submitted May 21, 1996;
accepted October 29, 1996.
Supported by National Institutes of Health grants no. DK/HL48714 and DK32294, the Office of Research and Development, Medical Research Service, Department of Veterans Affairs, and a grant from Amgen Inc.
Address reprint requests to Makio Ogawa, MD, PhD, VA Medical Center, 109 Bee St, Charleston, SC 29401-5799.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
We thank P.N. Pharr, A.G. Leary, and N.D. Grant for assistance in preparing the manuscript and H.Q. Zeng in FACS cell sorting.
| |
REFERENCES |
1.
Rosnet O,
Marchetto S,
deLapeyriere O,
Birnbaum D:
Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family.
Oncogene
6:1641,
1991[Medline]
[Order article via Infotrieve]
2.
Matthews W,
Jordan CT,
Wiegand GW,
Pardoll D,
Lemischka IR:
A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations.
Cell
65:1143,
1991[Medline]
[Order article via Infotrieve]
3.
Rosnet O,
Schiff C,
Pebusque M-J,
Marchetto S,
Tonnelle C,
Toiron Y,
Birg F,
Birnbaum D:
Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells.
Blood
82:1110,
1993[Abstract/Free Full Text]
4.
Small D,
Levenstein M,
Kim E,
Carow C,
Amin A,
Rockwell P,
Witte L,
Burrow C,
Ratajczak MZ,
Gewirtz AM,
Civin CI:
STK-1, the human homologue of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.
Proc Natl Acad Sci USA
91:459,
1994[Abstract/Free Full Text]
5.
Sherr CJ,
Rettenmier CW,
Sacca R,
Roussel MF,
Look AT,
Stanley ER:
The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
Cell
41:665,
1985[Medline]
[Order article via Infotrieve]
6.
Williams DE,
Eisenman J,
Baird A,
Rauch C,
Van Ness K,
March CJ,
Park LS,
Martin U,
Mochizuki DY,
Boswell HS,
Burgess GS,
Cosman D,
Lyman SD:
Identification of a ligand for the c-kit proto-oncogene.
Cell
63:167,
1990[Medline]
[Order article via Infotrieve]
7.
Zsebo KM,
Wypych J,
McNiece IK,
Lu HS,
Smith KA,
Karkare SB,
Sachdev RK,
Yuschenkoff VN,
Birkett NC,
Williams LR,
Satyagal VN,
Tung W,
Bosselman RA,
Mendiaz EA,
Langley KE:
Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium.
Cell
63:195,
1990[Medline]
[Order article via Infotrieve]
8.
Huang E,
Nocka K,
Beier DR,
Chu T-Y,
Buck J,
Lahm H-W,
Wellner D,
Leder P,
Besmer P:
The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.
Cell
63:225,
1990[Medline]
[Order article via Infotrieve]
9.
Ullrich A,
Schlessinger J:
Signal transduction by receptors with tyrosine kinase activity.
Cell
61:203,
1990[Medline]
[Order article via Infotrieve]
10.
Stanley ER,
Chen DM,
Lin H-S:
Induction of macrophage production and proliferation by a purified colony stimulating factor.
Nature
274:168,
1978[Medline]
[Order article via Infotrieve]
11.
Stanley ER,
Guilbert LJ,
Tushinski RJ,
Bartelmez SH:
CSF-1  A mononuclear phagocyte lineage-specific hemopoietic growth factor.
J Cell Biochem
21:151,
1983[Medline]
[Order article via Infotrieve]
12.
Metcalf D,
Nicola NA:
Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors.
Proc Natl Acad Sci USA
88:6239,
1991[Abstract/Free Full Text]
13.
Mackarehschian K,
Hardin JD,
Moore KA,
Boast S,
Goff SP,
Lemischka IR:
Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors.
Immunity
3:147,
1995[Medline]
[Order article via Infotrieve]
14.
Lyman SD,
James L,
Vanden Bos T,
de Vries P,
Brasel K,
Gliniak B,
Hollingsworth LT,
Picha KS,
McKenna HJ,
Splett RR,
Fletcher FF,
Maraskovsky E,
Farrah T,
Foxworthe D,
Williams DE,
Beckmann MP:
Molecular cloning of a ligand for the flt3/flk2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells.
Cell
75:1157,
1993[Medline]
[Order article via Infotrieve]
15.
Hannum C,
Culpepper J,
Campbell D,
McClanahan T,
Zurawski S,
Bazan JF,
Kastelein R,
Hudak S,
Wagner J,
Mattson J,
Luh J,
Duda G,
Martina N,
Peterson D,
Menon S,
Scanafelt A,
Muench M,
Kelner G,
Namikawa R,
Rennick D,
Roncarolo M-G,
Zlotnik A,
Rosnet O,
Dubreuil P,
Birnbaum D,
Lee F:
Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
Nature
368:643,
1994[Medline]
[Order article via Infotrieve]
16.
Muench MO,
Roncarolo MG,
Menon S,
Xu Y,
Kastelein R,
Zurawski S,
Hannum CH,
Culpepper J,
Lee F,
Namikawa R:
FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.
Blood
85:963,
1995[Abstract/Free Full Text]
17.
Hirayama F,
Lyman SD,
Clark SC,
Ogawa M:
The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors.
Blood
85:1762,
1995[Abstract/Free Full Text]
18.
Jacobsen SEW,
Okkenhaug C,
Myklebust J,
Veiby OP:
The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: Synergistic interactions with interleukin (IL)-11, IL-12, and other hematopoietic growth factors.
J Exp Med
181:1357,
1995[Abstract/Free Full Text]
19.
Broxmeyer HE,
Lu L,
Cooper S,
Ruggieri L,
Li Z-H,
Lyman SD:
Flt3 ligand stimulates/costimulates the growth of myeloid stem/progenitor cells.
Exp Hematol
23:1121,
1995[Medline]
[Order article via Infotrieve]
20.
Hudak S,
Hunte B,
Culpepper J,
Menon S,
Hannum C,
Thompson-Snipes LA,
Rennick D:
FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
Blood
85:2747,
1995[Abstract/Free Full Text]
21.
Gabbianelli M,
Pelosi E,
Montesoro E,
Valtieri M,
Luchetti P,
Samoggia P,
Vitelli L,
Barberi T,
Testa U,
Lyman SD,
Peschle C:
Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Blood
86:1661,
1995[Abstract/Free Full Text]
22.
Tsuji K,
Zsebo KM,
Ogawa M:
Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit.
Blood
78:1223,
1991[Abstract/Free Full Text]
23.
Hirayama F,
Shih JP,
Awgulewitsch A,
Warr GW,
Clark SC,
Ogawa M:
Clonal proliferation of murine lymphohemopoietic progenitors in culture.
Proc Natl Acad Sci USA
89:5907,
1992[Abstract/Free Full Text]
24.
Katayama N,
Clark SC,
Ogawa M:
Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors.
Blood
81:610,
1992[Abstract/Free Full Text]
25.
Tsuji K,
Lyman SD,
Sudo T,
Clark SC,
Ogawa M:
Enhancement of murine hemopoiesis by synergistic interactions between Steel factor (ligand for c-kit ), interleukin-11 and other early-acting factors in culture.
Blood
79:2855,
1992[Abstract/Free Full Text]
26.
Hirayama F,
Katayama N,
Neben S,
Donaldson D,
Nickbarg EB,
Clark SC,
Ogawa M:
Synergistic interaction between interleukin-12 and Steel factor in support of proliferation of murine lymphohemopoietic progenitors in culture.
Blood
83:92,
1994[Abstract/Free Full Text]
27.
Heimfeld S,
Hudak S,
Weissman I,
Rennick D:
The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors.
Proc Natl Acad Sci USA
88:9902,
1991[Abstract/Free Full Text]
28.
Bodine DM,
Crosier PS,
Clark SC:
Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture.
Blood
78:914,
1991[Abstract/Free Full Text]
29.
Miura N,
Okada S,
Zsebo KM,
Miura Y,
Suda T:
Rat stem cell factor and IL-6 preferentially support the proliferation of c-kit-positive murine hemopoietic cells rather than their differentiation.
Exp Hematol
21:143,
1993[Medline]
[Order article via Infotrieve]
30.
Muench MO,
Firpo MT,
Moore MA:
Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential.
Blood
81:3463,
1993[Abstract/Free Full Text]
31.
Rebel VI,
Dragowska W,
Eaves CJ,
Humphries RK,
Lansdorp PM:
Amplification of Sca-1+Lin-WGA+ cells in serum-free cultures containing Steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential.
Blood
83:128,
1994[Abstract/Free Full Text]
32.
Knobel KM,
McNally MA,
Berson AE,
Rood D,
Chen K,
Kilinski L,
Tran K,
Okarma TB,
Lebkowski JS:
Long-term reconstitution of mice after ex vivo expansion of bone marrow cells: Differential activity of cultured bone marrow and enriched stem cell populations.
Exp Hematol
22:1227,
1994[Medline]
[Order article via Infotrieve]
33.
Peters SO,
Kittler ELW,
Ramshaw HS,
Quesenberry PJ:
Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts.
Exp Hematol
23:461,
1995[Medline]
[Order article via Infotrieve]
34.
Brandt J,
Briddell RA,
Srour EF,
Leemhuis TB,
Hoffman R:
Role of c-kit ligand in the expansion of human hematopoietic progenitor cells.
Blood
79:634,
1992[Abstract/Free Full Text]
35.
Haylock DN,
To LB,
Dowse TL,
Juttner CA,
Simmons PJ:
Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage.
Blood
80:1405,
1992[Abstract/Free Full Text]
36.
Sato N,
Sawada K,
Koizumi K,
Tarumi T,
Ieko M,
Yasukouchi T,
Yamaguchi M,
Takahashi TA,
Sekiguchi S,
Koike T:
In vitro expansion of human peripheral blood CD34+ cells.
Blood
82:3600,
1993[Abstract/Free Full Text]
37.
Lansdorp PM,
Dragowska W,
Mayani H:
Ontogeny-related changes in proliferative potential of human hematopoietic cells.
J Exp Med
178:787,
1993[Abstract/Free Full Text]
38.
Brugger W,
Möcklin W,
Heimfeld S,
Berenson RJ,
Mertelsmann R,
Kanz L:
Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 (IL-1), IL-6, IL-3, interferon- , and erythropoietin.
Blood
81:2579,
1993[Abstract/Free Full Text]
39.
Flasshove M,
Banerjee D,
Mineishi S,
Li MX,
Bertino JR,
Moore MAS:
Ex vivo expansion and selection of human CD34 peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.
Blood
85:566,
1995[Abstract/Free Full Text]
40.
Rice A,
Boiron JM,
Barbot C,
Dupouy M,
Dubosc-Marchenay N,
Dumain P,
Lacombe F,
Reiffers J:
Cytokine-mediated expansion of 5-FU-resistant peripheral blood cells.
Exp Hematol
23:303,
1995[Medline]
[Order article via Infotrieve]
41.
Ogawa M:
Differentiation and proliferation of hematopoietic stem cells.
Blood
81:2844,
1993[Abstract/Free Full Text]
42.
Shih JP,
Zeng HQ,
Ogawa M:
Enrichment of murine marrow cells for progenitors of multilineage hematopoietic colonies.
Leukemia
6:193,
1992[Medline]
[Order article via Infotrieve]
43.
Ortega G,
Korty PE,
Shevach EM,
Malek TR:
Role of Ly-6 in lymphocyte activation. I. Characterization of a monoclonal antibody to a nonpolymorphic Ly-6 specificity.
J Immunol
137:3240,
1986[Abstract]
44.
Nishikawa S,
Kusakabe M,
Yoshinaga K,
Ogawa M,
Hayashi S,
Kunisada T,
Era T,
Sakakura T,
Nishikawa S-I:
In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: Two distinct waves of c-kit-dependency during melanocyte development.
EMBO J
10:2111,
1991[Medline]
[Order article via Infotrieve]
45.
Nakahata T,
Ogawa M:
Clonal origin of murine hemopoietic colonies with apparent restriction to granulocyte-macrophage-megakaryocyte (GMM) differentiation.
J Cell Physiol
111:239,
1982[Medline]
[Order article via Infotrieve]
46.
Nakahata T,
Ogawa M:
Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies.
Proc Natl Acad Sci USA
79:3843,
1982[Abstract/Free Full Text]
47.
Harrison DE,
Astle CM,
Delaittre JA:
Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging.
J Exp Med
147:1526,
1978[Abstract/Free Full Text]
48.
Hirayama F,
Clark SC,
Ogawa M:
Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1.
Proc Natl Acad Sci USA
91:469,
1994[Abstract/Free Full Text]
49.
Hirayama F,
Ogawa M:
Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1.
Blood
86:4527,
1995[Abstract/Free Full Text]
50.
Yonemura Y,
Ku H,
Hirayama F,
Souza LM,
Ogawa M:
Interleukin-3 or interleukin-1 abrogates the reconstituting ability of hematopoietic stem cells.
Proc Natl Acad Sci USA
93:4040,
1996[Abstract/Free Full Text]
51.
Peters SO,
Kittler ELW,
Ramshaw HS,
Quesenberry PJ:
Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts.
Blood
87:30,
1996[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Seita, M. Asakawa, J. Ooehara, S.-i. Takayanagi, Y. Morita, N. Watanabe, K. Fujita, M. Kudo, J. Mizuguchi, H. Ema, et al.
Interleukin-27 directly induces differentiation in hematopoietic stem cells
Blood,
February 15, 2008;
111(4):
1903 - 1912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. Visconti, Y. Ebihara, A. C. LaRue, P. A. Fleming, T. C. McQuinn, M. Masuya, H. Minamiguchi, R. R. Markwald, M. Ogawa, and C. J. Drake
An In Vivo Analysis of Hematopoietic Stem Cell Potential: Hematopoietic Origin of Cardiac Valve Interstitial Cells
Circ. Res.,
March 17, 2006;
98(5):
690 - 696.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. De Felice, C. Tatarelli, M. G. Mascolo, C. Gregorj, F. Agostini, R. Fiorini, V. Gelmetti, S. Pascale, F. Padula, M. T. Petrucci, et al.
Histone Deacetylase Inhibitor Valproic Acid Enhances the Cytokine-Induced Expansion of Human Hematopoietic Stem Cells
Cancer Res.,
February 15, 2005;
65(4):
1505 - 1513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Zhang and H. F. Lodish
Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells
Blood,
April 1, 2004;
103(7):
2513 - 2521.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Helgason, J. Antonchuk, C. Bodner, and R. K. Humphries
Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice
Blood,
November 15, 2003;
102(10):
3541 - 3547.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Karlsson, M. Engstrom, M. Jonsson, P. Karlberg, C. J.H. Pronk, J. Richter, and J.-I. Jonsson
Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes
J. Leukoc. Biol.,
November 1, 2003;
74(5):
923 - 931.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Masuya, C. J. Drake, P. A. Fleming, C. M. Reilly, H. Zeng, W. D. Hill, A. Martin-Studdard, D. C. Hess, and M. Ogawa
Hematopoietic origin of glomerular mesangial cells
Blood,
March 15, 2003;
101(6):
2215 - 2218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Pinto do O, K. Richter, and L. Carlsson
Hematopoietic progenitor/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo
Blood,
May 13, 2002;
99(11):
3939 - 3946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Christensen and I. L. Weissman
Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells
PNAS,
November 20, 2001;
(2001)
261562798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. J. Summers, C. M. Heyworth, E. A. de Wynter, J. Chang, and N. G. Testa
| |
Abstract
Introduction
Abstract